"Adrenergic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters.
| Descriptor ID |
D018663
|
| MeSH Number(s) |
D27.505.519.625.050 D27.505.696.577.050
|
| Concept/Terms |
Adrenergic Agents- Adrenergic Agents
- Agents, Adrenergic
- Adrenergics
- Adrenergic Drugs
- Drugs, Adrenergic
Adrenergic Effect- Adrenergic Effect
- Effect, Adrenergic
- Adrenergic Effects
- Effects, Adrenergic
Adrenergic Neuron Agents- Adrenergic Neuron Agents
- Agents, Adrenergic Neuron
- Neuron Agents, Adrenergic
- Adrenergic Neuron Drugs
- Drugs, Adrenergic Neuron
- Neuron Drugs, Adrenergic
|
Below are MeSH descriptors whose meaning is more general than "Adrenergic Agents".
Below are MeSH descriptors whose meaning is more specific than "Adrenergic Agents".
This graph shows the total number of publications written about "Adrenergic Agents" by people in this website by year, and whether "Adrenergic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 3 | 3 |
| 2009 | 1 | 1 | 2 |
| 2011 | 0 | 2 | 2 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adrenergic Agents" by people in Profiles.
-
Connell AR, Hookham MB, Fu D, Brazil DP, Lyons TJ, Yu JY. Comparisons of a2-Adrenergic Agents, Medetomidine and Xylazine, with Pentobarbital for Anesthesia: Important Pitfalls in Diabetic and Nondiabetic Rats. J Ocul Pharmacol Ther. 2022 03; 38(2):156-166.
-
Gorelova N, Mulholland PJ, Chandler LJ, Seamans JK. The glutamatergic component of the mesocortical pathway emanating from different subregions of the ventral midbrain. Cereb Cortex. 2012 Feb; 22(2):327-36.
-
Brady KT, Gray KM, Tolliver BK. Cognitive enhancers in the treatment of substance use disorders: clinical evidence. Pharmacol Biochem Behav. 2011 Aug; 99(2):285-94.
-
Dickerson LM, Carek PJ. Pharmacotherapy for the obese patient. Prim Care. 2009 Jun; 36(2):407-15.
-
Egger C, McCrackin MA, Hofmeister E, Touzot-Jourde G, Rohrbach B. Efficacy of preanesthetic intramuscular administration of ephedrine for prevention of anesthesia-induced hypotension in cats and dogs. Can Vet J. 2009 Feb; 50(2):179-84.
-
Lelliott CJ, Medina-Gomez G, Petrovic N, Kis A, Feldmann HM, Bjursell M, Parker N, Curtis K, Campbell M, Hu P, Zhang D, Litwin SE, Zaha VG, Fountain KT, Boudina S, Jimenez-Linan M, Blount M, Lopez M, Meirhaeghe A, Bohlooly-Y M, Storlien L, Strömstedt M, Snaith M, Oresic M, Abel ED, Cannon B, Vidal-Puig A. Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance. PLoS Biol. 2006 Nov; 4(11):e369.
-
Nathan RA, Finn AF, LaForce C, Ratner P, Chapman D, de Guia EC, Hewlett D, Kramer B. Comparison of cetirizine-pseudoephedrine and placebo in patients with seasonal allergic rhinitis and concomitant mild-to-moderate asthma: randomized, double-blind study. Ann Allergy Asthma Immunol. 2006 Sep; 97(3):389-96.
-
Quintero EM, Willis L, Singleton R, Harris N, Huang P, Bhat N, Granholm AC. Behavioral and morphological effects of minocycline in the 6-hydroxydopamine rat model of Parkinson's disease. Brain Res. 2006 Jun 06; 1093(1):198-207.
-
Brimijoin S, Molinoff PB. Effects of 6-hydroxydopamine on the activity of tyrosine hydroxylase and dopamine- -hydroxylase in sympathetic ganglia of the rat. J Pharmacol Exp Ther. 1971 Sep; 178(3):417-24.